Group One Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-45,300
Closed -$2.38M 7354
2020
Q3
$2.38M Buy
45,300
+44,100
+3,675% +$1.83M 0.01% 1467
2020
Q2
$40K Sell
1,200
-1,300
-52% -$41.4K ﹤0.01% 4502
2020
Q1
$68K Buy
+2,500
New +$69.6K ﹤0.01% 3545
2019
Q3
Sell
-2,000
Closed -$25K 5799
2019
Q2
$25K Hold
2,000
﹤0.01% 4087
2019
Q1
$29K Buy
+2,000
New +$25.5K ﹤0.01% 3868
2018
Q4
Sell
-13,000
Closed -$342K 5707
2018
Q3
$342K Buy
+13,000
New +$351K ﹤0.01% 2604
2016
Q4
Sell
-1,200
Closed -$14K 5033
2016
Q3
$14K Buy
+1,200
New +$14.1K ﹤0.01% 3942
2015
Q4
Sell
-4,000
Closed -$66K 5292
2015
Q3
$66K Buy
4,000
+3,200
+400% +$65.5K ﹤0.01% 3355
2015
Q2
$18K Buy
+800
New +$15.9K ﹤0.01% 4083
2015
Q1
Sell
-5,300
Closed -$64K 5395
2014
Q4
$64K Buy
5,300
+200
+4% +$2.29K ﹤0.01% 3200
2014
Q3
$58K Sell
5,100
-53,900
-91% -$615K ﹤0.01% 3419
2014
Q2
$713K Buy
59,000
+19,300
+49% +$228K 0.01% 1371
2014
Q1
$463K Sell
39,700
-14,400
-27% -$244K 0.01% 1693
2013
Q4
$956K Buy
54,100
+43,800
+425% +$736K 0.01% 1131
2013
Q3
$148K Buy
10,300
+5,800
+129% +$88.8K ﹤0.01% 2662
2013
Q2
$68K Buy
+4,500
New +$59.4K ﹤0.01% 3159

Group One Trading's MNTA Position: Q3 2019 in Review

Group One Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2019, closing a stake of 1,200 shares — an estimated $14.5K sold.

Group One Trading first reported a position in MNTA in Q4 2013 and held it in 13 quarters. The position peaked at $369K in Q2 2014. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

  • Group One Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 1,200 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $14.5K.
  • Group One Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 13 quarters.
  • Group One Trading's Momenta Pharmaceuticals, Inc. position peaked at $369K in Q2 2014.
  • 154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.